$DSNKY News Article - Daiichi Sankyo Presents Positive Results of the First Randomised, Controlled Trial of Uninterrupted Oral, Once-daily LIXIANA ? (edoxaban) in Atrial Fibrillation Patients Undergoing Catheter Ablation https://marketwirenews.com/news-releases/daii...53472.html
My Twitter: WhyteStocks